Idenix Pharmaceuticals' P2P Acquisition

Idenix Pharmaceuticals raised a round of funding on August 05, 2014. Investors include Merck & Co..

Idenix Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix is headquartered in Cambridge, Massachusetts (…

Articles about Idenix Pharmaceuticals' P2P Acquisition: